These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24841819)

  • 1. [Progression of pharmacologic vitreolysis research].
    Zhou H; Ye J
    Zhonghua Yan Ke Za Zhi; 2014 Mar; 50(3):225-9. PubMed ID: 24841819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Efficacy and Safety Profile of Ocriplasmin in Vitreomacular Interface Disorders.
    Shaikh M; Miller JB; Papakostas TD; Husain D
    Semin Ophthalmol; 2017; 32(1):52-55. PubMed ID: 27786583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic Vitreolysis for Vitreomacular Traction in Diabetic Retinopathy.
    Rizzo S; Bacherini D
    Dev Ophthalmol; 2017; 60():160-164. PubMed ID: 28427074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis.
    Stalmans P; Duker JS; Kaiser PK; Heier JS; Dugel PU; Gandorfer A; Sebag J; Haller JA
    Retina; 2013; 33(10):2003-11. PubMed ID: 23881226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From the analysis of pharmacologic vitreolysis to the comprehension of ocriplasmin safety.
    Morescalchi F; Gambicorti E; Duse S; Costagliola C; Semeraro F
    Expert Opin Drug Saf; 2016 Sep; 15(9):1267-78. PubMed ID: 27388220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic vitreolysis.
    Gandorfer A
    Dev Ophthalmol; 2007; 39():149-156. PubMed ID: 17245084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective of pharmacologic vitreolysis.
    Gandorfer A
    Dev Ophthalmol; 2009; 44():1-6. PubMed ID: 19494646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic vitreolysis in diabetic retinopathy.
    El-Asrar AM; Al-Mezain HS
    Curr Pharm Biotechnol; 2011 Mar; 12(3):406-9. PubMed ID: 20939804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel vitreous modulators for pharmacologic vitreolysis in the treatment of diabetic retinopathy.
    Costa Ede P; Rodrigues EB; Farah ME; Sebag J; Meyer CH
    Curr Pharm Biotechnol; 2011 Mar; 12(3):410-22. PubMed ID: 20939794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocriplasmin for pharmacologic vitreolysis.
    Kuppermann BD
    Retina; 2012 Sep; 32 Suppl 2():S225-8; discussion S228-31. PubMed ID: 22929326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological vitreolysis].
    Gandorfer A
    Klin Monbl Augenheilkd; 2011 Mar; 228(3):201-7. PubMed ID: 20845257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic vitreolysis with ocriplasmin: rationale for use and therapeutic potential in vitreo-retinal disorders.
    Khoshnevis M; Sebag J
    BioDrugs; 2015 Apr; 29(2):103-12. PubMed ID: 25812991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research update of ocriplasmin for symptomatic vitreomacular adhesion].
    Zhang M; Chen Y
    Zhonghua Yan Ke Za Zhi; 2014 Nov; 50(11):866-70. PubMed ID: 25582211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic vitreolysis.
    Rhéaume MA; Vavvas D
    Semin Ophthalmol; 2010; 25(5-6):295-302. PubMed ID: 21091015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic Vitreolysis in Vascular Diseases of the Retina.
    Soliman MK; Agarwal A; Sarwar S; Hanout M; Sadiq MA; Do DV; Nguyen QD
    Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):60-8. PubMed ID: 26731211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial.
    de Smet MD; Gandorfer A; Stalmans P; Veckeneer M; Feron E; Pakola S; Kampik A
    Ophthalmology; 2009 Jul; 116(7):1349-55, 1355.e1-2. PubMed ID: 19447497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic Vitrectomy and Pharmacologic Vitreodynamics.
    Shah AR; Trese MT
    Dev Ophthalmol; 2016; 55():357-64. PubMed ID: 26501959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of Vitreomacular Traction.
    Wan R; Hong T; Tariq Y; Chang A
    Curr Pharm Des; 2018; 24(41):4874-4881. PubMed ID: 30674252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic vitreolysis using reengineered
    Santra M; Sharma M; Katoch D; Jain S; Saikia UN; Dogra MR; Luthra-Guptasarma M
    Mol Vis; 2021; 27():125-141. PubMed ID: 33907368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biology of pharmacologic vitreolysis.
    Sebag J
    Trans Am Ophthalmol Soc; 2005; 103():473-94. PubMed ID: 17057814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.